We recently compiled a list of the 13 Highest Yielding Dividend Stocks in the Dow. In this article, we are going to take a ...

with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 0.05% higher. Amgen currently has a Zacks Rank of #3 (Hold).

We recently published a list of 15 Best NASDAQ Dividend Stocks To Buy. In this article, we are going to take a look at where ...

Amgen (NASDAQ:AMGN) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

One of the more heavily weighted stocks in the index is the pharmaceutical giant, Amgen (AMGN). Overall, I am bullish enough about the stock to initiate coverage with a Buy rating. Discover the ...

Deep-pocketed investors have adopted a bearish approach towards Amgen (NASDAQ:AMGN), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled ...

Currently, Amgen's stock is trading at $272.83, up 1.26 percent on the Nasdaq. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

At the same time, the Dow lost 0.06%, and the tech-heavy Nasdaq gained 1.24%. The upcoming earnings release of Amgen will be of great interest to investors. In that report, analysts expect Amgen ...

with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.06% higher. At present, Amgen boasts a Zacks Rank of ...

Amgen's 23% year-over-year revenue growth to ... Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and CRISPR Therapeutics wasn’t one ...

with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, there's been a 0.11% rise in the Zacks Consensus EPS estimate. At present, Amgen boasts a ...